feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / ADHD Patients Face Medication Cost Crisis

ADHD Patients Face Medication Cost Crisis

9 Dec, 2025

•

Summary

  • Patients with private ADHD diagnoses struggle with high medication costs.
  • One father faces approximately £1,500 annually for medication and assessments.
  • GPs can refuse NHS prescriptions for shared care agreements due to capacity.
ADHD Patients Face Medication Cost Crisis

Individuals diagnosed with ADHD privately are confronting substantial out-of-pocket expenses for necessary medications and ongoing assessments. One father's experience underscores this challenge, with annual costs reaching approximately £1,500. His attempt to secure an NHS prescription was unsuccessful, leading to calls for improved patient treatment and support.

This financial strain arises because GPs can opt out of shared care agreements, a system designed to integrate private specialist care with NHS prescriptions. Such refusals are permitted if healthcare providers deem they lack the capacity to ensure safe and effective patient management.

The government acknowledges this flexibility for GPs, emphasizing that patient safety remains paramount. However, the current system creates significant barriers for those seeking affordable ADHD treatment, prompting concerns about equitable access to care.

trending

HCL Tech Q3 results

trending

HYDRAA Prajavani receives complaints

trending

Jio Hotstar acquire Raja Saab?

trending

Bharat Coking Coal IPO

trending

Amagi Media Labs IPO opens

trending

Tata Punch facelift features revealed

trending

Delhi temperature drops amid cold

trending

Celebrities star in more ads

trending

Paris FC knocks out PSG

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
GPs can refuse shared care agreements for private diagnoses if they lack the capacity to ensure safe patient care.
Annual costs for medication and assessments can amount to approximately £1,500 for some patients.
It's an agreement where GPs take over prescription responsibility from private specialists for continuity of care.

Read more news on

Healthside-arrow

You may also like

ADHD Care: A 'Wild West' for Patients?

30 mins ago

article image

ADHD Meds Boost Alertness, Not Focus Directly

26 Dec, 2025 • 102 reads

article image

Girls' ADHD Overlooked: Study Reveals School Blind Spots

14 Dec, 2025 • 147 reads

article image

Running Late? ADHD Might Be The Reason

14 Dec, 2025 • 134 reads

article image

Ontario Sees 157% Rise in ADHD Prescriptions

12 Dec, 2025 • 148 reads